Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             37 results found
no title author magazine year volume issue page(s) type
1 An unusual BRCA2 allele carrying two splice site mutations Colombo, M.

20 6 p. 1143-1144
article
2 A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102 Philips, G.K.

20 6 p. 1074-1079
article
3 A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC) Socinski, M.A.

20 6 p. 1068-1073
article
4 A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group Ray-Coquard, I.

20 6 p. 1105-1112
article
5 Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden Ji, J.

20 6 p. 1121-1126
article
6 Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications Cabioglu, N.

20 6 p. 1013-1019
article
7 Classification of biliary tract cancer (BTC): evaluation of all entities Tonini, G.

20 6 p. 1148-1149
article
8 Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Nordlinger, B.

20 6 p. 985-992
article
9 Comment on ‘Older cancer patients in an Italian hospice’ Errante, D.

20 6 p. 1146-1147
article
10 DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer Postma, C.

20 6 p. 1048-1056
article
11 Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer Byström, P.

20 6 p. 1057-1061
article
12 Editorial Board
20 6 p. ii-iii
article
13 Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study Bidard, F.-C.

20 6 p. 1042-1047
article
14 Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma Younes, A.

20 6 p. 1147-1148
article
15 FDG–PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer? Arslan, C.

20 6 p. 1149-1150
article
16 Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment Falchook, G.S.

20 6 p. 1080-1085
article
17 High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer Spillane, A.J.

20 6 p. 977-984
article
18 in this issue
20 6 p. 971
article
19 Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer Kioulafa, M.

20 6 p. 1020-1025
article
20 Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type Stathis, A.

20 6 p. 1086-1093
article
21 Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases Aljubran, A.H.

20 6 p. 1136-1141
article
22 Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study Celio, L.

20 6 p. 1062-1067
article
23 Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia Chen, C.-Y.

20 6 p. 1100-1104
article
24 Prognostic significance of histological grade in clear-cell carcinoma of the ovary: a retrospective study of Korean Gynecologic Oncology Group Ryu, S.-Y.

20 6 p. 1032-1036
article
25 Reply to Classification of biliary tract cancer (BTC): evaluation of all entities Randi, G.

20 6 p. 1149
article
26 Reply to FDG–PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer? Byström, P.

20 6 p. 1150
article
27 Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer Buzdar, A.U.

20 6 p. 993-999
article
28 Sentinel lymph node biopsy for staging early breast cancer: minimizing the trade-off by maximizing the accuracy Gadd, Michele

20 6 p. 973-975
article
29 Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial Canavese, G.

20 6 p. 1001-1007
article
30 Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens Blackwell, K.L.

20 6 p. 1026-1031
article
31 Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database Salas, S.

20 6 p. 1127-1135
article
32 ‘Sunitinib withdrawal phenomenon’ or spontaneous regression in renal cell cancer Rothermundt, C.A.

20 6 p. 1144-1146
article
33 Table of Contents
20 6 p. iv-v
article
34 The prognostic value of DNA ploidy in a total population of uterine sarcomas Kildal, W.

20 6 p. 1037-1041
article
35 The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma Lehnerdt, G.F.

20 6 p. 1094-1099
article
36 Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172210 men and women: a prospective 19-year follow-up study Strasak, A.M.

20 6 p. 1113-1120
article
37 Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome Botteri, E.

20 6 p. 1008-1012
article
                             37 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands